logo
Plus   Neg
Share
Email

Dechra Pharma To Acquire Worldwide Rights To Osurnia From Elanco - Quick Facts

Elanco Animal Health Inc. (ELAN) has agreed to divest Osurnia, a treatment for otitis externa in dogs, to Dechra Pharmaceuticals (DPH.L) for $135 million. This deal is related to Elanco's acquisition of Bayer AG's (BAYZF.PK,BAYRY.PK,BYR.L) animal health business, which is subject to regulatory approval from the European Commission and the Federal Trade Commission.

Osurnia had 2018 annual revenue of $31.2 million. Dechra Pharma expects the acquisition to be earnings enhancing for the financial year ending 30 June 2021.

Ian Page, Dechra's CEO stated: "The addition of Osurnia will allow us to offer an extended range of solutions for veterinarians to manage otitis externa and offer the best treatment for the pet taking into consideration the veterinarians clinical preference and the owners lifestyle."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>